These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9807676)

  • 1. The changing incidence of lymphoproliferative disorders in Yorkshire.
    Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R
    Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
    Naresh KN; Srinivas V; Soman CS
    Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
    Cool CD; Bitter MA
    Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of lymphoproliferative diseases in Northern Italy].
    Milani M; Tricomi P; Zuccoli E; Rossi G; Pezzotta MG; Lari C; Cristofori E
    Pathologica; 1996 Dec; 88(6):478-82. PubMed ID: 9206774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non Hodgkin lymphoma in the North-East Bosnia--changes in biological aggressiveness and primary presentation of the disease].
    Halilbasić A; Mesic E; Cikusić E; Arnautović A
    Med Arh; 2006; 60(6 Suppl 2):78-83. PubMed ID: 18172989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extranodal lymphomas in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of 30 years' epidemiologic data].
    Jakó J; Szerafin L
    Orv Hetil; 2015 Jan; 156(3):98-104. PubMed ID: 25577681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
    Mitarnun W; Suwiwat S; Pradutkanchana J
    Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
    Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML
    Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group.
    Morgan G; Vornanen M; Puitinen J; Naukkarinen A; Brincker H; Olsen J; Coeburgh JW; Vrints LW; Clayden D; McNally R; Jack A; Carli PM; Petrella T; Tomino R; D'Lollo S; Barchielli A; Cartwright R
    Ann Oncol; 1997; 8 Suppl 2():49-54. PubMed ID: 9209641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lympho-hemopoietic malignancies in India.
    Bhutani M; Vora A; Kumar L; Kochupillai V
    Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
    Altieri A; Bermejo JL; Hemminki K
    Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.
    Naresh KN; Agarwal B; Nathwani BN; Diebold J; McLennan KA; Muller-Hermelink KH; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 2004 Aug; 45(8):1569-77. PubMed ID: 15370208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
    Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
    Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.